Hwaseong-si, South Korea

Hyun Soo Ryu

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Hwaseong-si, KR (2023)
  • Seoul, KR (2023)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hyun Soo Ryu: Innovator in Immunostimulating IL-2 Analogs

Introduction

Hyun Soo Ryu is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology, particularly through his work on interleukin-2 (IL-2) analogs. With a total of 3 patents to his name, Ryu's innovations are paving the way for advancements in immunotherapy.

Latest Patents

Ryu's latest patents focus on immunostimulating IL-2 analogs. One of his notable inventions involves modifications to interleukin-2 alpha receptors. Additionally, he has developed interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors. These advancements are crucial for enhancing the efficacy of immunotherapies.

Career Highlights

Hyun Soo Ryu is currently associated with Hanmi Pharm. Co., Ltd., where he continues to push the boundaries of medical research. His work has garnered attention for its potential to improve treatment options for various diseases.

Collaborations

Ryu collaborates with esteemed colleagues, including Euh Lim Oh and Sang Yun Kim. Their combined expertise contributes to the innovative research being conducted at Hanmi Pharm.

Conclusion

Hyun Soo Ryu's contributions to the field of immunology through his patents on IL-2 analogs highlight his role as a key innovator. His work not only advances scientific understanding but also holds promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…